HISAMITSU PHARMA, 1% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 30 yen

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Thu Apr 10, 2025 3:30 pm JST Earnings

4530 HISAMITSU PHARMACEUTICAL CO.,INC. 【J-GAAP】

Earnings Report

HISAMITSU PHARMACEUTICAL CO.,INC. <4530> [TSE Prime] announced its financial results after the market closed on April 10th (15:30). The consolidated ordinary profit for the fiscal year ending February 2025 increased 22.2% from the previous period to 24 billion yen. In the fiscal year ending February 2026, the profit is expected to grow by 1.2% to 24.3 billion yen. This will be the fifth consecutive term of revenue and profit growth.

At the same time, the company has decided to increase the dividend this fiscal year to 120 yen, an increase of 30 yen from the previous fiscal year.

In the most recent three-month period, from December to February (4Q), the consolidated ordinary profit surged 2.5 times that of the same period last year, reaching 7.53 billion yen. The operating profit margin drastically improved from 2.4% in the same period last year to 12.7%.

Kabutan News

Actual Results

Historical Performance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Feb, 2023	128,330	11,599	16,051	11,742	148.0	84.50	Apr 13, 2023	J-GAAP
Feb, 2024	141,706	13,167	19,649	13,969	181.6	85	Apr 11, 2024	J-GAAP
Feb, 2025	156,006	18,895	24,010	21,758	295.6	90	Apr 10, 2025	J-GAAP
YoY	+10.1%	+43.5%	+22.2%	+55.8%	+62.7%

Full Year Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Feb, 2025 Guidance	154,000	18,000	23,000	20,500	281.1	90	Jan 9, 2025	J-GAAP
Feb, 2025 Results	156,006	18,895	24,010	21,758	295.6	90	Apr 10, 2025	J-GAAP
Revision Rate	+1.3%	+5.0%	+4.4%	+6.1%	+5.2%

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar - Aug, 2024	75,456	9,006	10,788	9,098	122.7	45	Oct 10, 2024	J-GAAP
Mar - Aug, 2025 Guidance	ー	ー	ー	ー	－	60	Apr 10, 2025	J-GAAP
YoY	－	－	－	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Feb, 2024	141,706	13,167	19,649	13,969	181.6	85	Apr 11, 2024	J-GAAP
Feb, 2025	156,006	18,895	24,010	21,758	295.6	90	Apr 10, 2025	J-GAAP
Feb, 2026 Guidance	165,000	20,000	24,300	22,000	301.5	120	Apr 10, 2025	J-GAAP
YoY	+5.8%	+5.8%	+1.2%	+1.1%	+2.0%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Dec - Feb, 2023	38,879	921	3,011	1,877	24.4	2.4	Apr 11, 2024	J-GAAP
Mar - May, 2024	35,810	4,149	5,562	4,788	63.9	11.6	Jul 11, 2024	J-GAAP
Jun - Aug, 2024	39,646	4,857	5,226	4,310	58.1	12.3	Oct 10, 2024	J-GAAP
Sep - Nov, 2024	35,797	4,214	5,683	4,562	61.8	11.8	Jan 9, 2025	J-GAAP
Dec - Feb, 2024	44,753	5,675	7,539	8,098	110.0	12.7	Apr 10, 2025	J-GAAP
YoY	+15.1%	+516.2%	+150.4%	+331.4%	+350.9%